Urothelial carcinoma; an overview of histology, molecular subtypes, and clinical implications based on the latest WHO classification

The incidence of urothelial carcinoma is increasing worldwide (including in Iran). Bladder cancer can be classified in various manners according to the standardized histomorphology set by the World Health Organization (WHO). Various genetic modifications occurring at the DNA level and the resulting...

Full description

Bibliographic Details
Main Authors: Fateme Khalatbari, Miremad Moafi-Madani, Ali Amin
Format: Article
Language:English
Published: Society of Diabetic Nephropathy Prevention 2023-09-01
Series:Journal of Nephropathology
Subjects:
Online Access:https://nephropathol.com/PDF/jnp-12-e21482.pdf
_version_ 1797676485390106624
author Fateme Khalatbari
Miremad Moafi-Madani
Ali Amin
author_facet Fateme Khalatbari
Miremad Moafi-Madani
Ali Amin
author_sort Fateme Khalatbari
collection DOAJ
description The incidence of urothelial carcinoma is increasing worldwide (including in Iran). Bladder cancer can be classified in various manners according to the standardized histomorphology set by the World Health Organization (WHO). Various genetic modifications occurring at the DNA level and the resulting variations in RNA expression give rise to different subcategories that have important implications for diagnosis, prognosis, and treatment. The molecular basis of these morphologic variances is now better understood because of recent developments in molecular biology. With updates on the genetic and clinical characteristics, we highlight the histologic traits of the divergent differentiation and subtypes recognized by the most recent WHO classification (5th edition). Molecular subtypes of lower and upper tract cancer can be used to characterize their clinical behaviors and determine therapeutic responses to neoadjuvant chemotherapy. In this overview article, we also present a preliminary analysis of our ongoing data collection on molecular features of urothelial carcinoma.
first_indexed 2024-03-11T22:28:49Z
format Article
id doaj.art-624f76b696954d0d9d3b8e8436098c26
institution Directory Open Access Journal
issn 2251-8363
2251-8819
language English
last_indexed 2024-03-11T22:28:49Z
publishDate 2023-09-01
publisher Society of Diabetic Nephropathy Prevention
record_format Article
series Journal of Nephropathology
spelling doaj.art-624f76b696954d0d9d3b8e8436098c262023-09-23T11:33:13ZengSociety of Diabetic Nephropathy PreventionJournal of Nephropathology2251-83632251-88192023-09-01124e21482e2148210.34172/jnp.2023.21482jnp-21482Urothelial carcinoma; an overview of histology, molecular subtypes, and clinical implications based on the latest WHO classificationFateme Khalatbari0Miremad Moafi-Madani1Ali Amin2Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, USADepartment of Epidemiology, Brown University, Providence, Rhode Island, USADepartment of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, USAThe incidence of urothelial carcinoma is increasing worldwide (including in Iran). Bladder cancer can be classified in various manners according to the standardized histomorphology set by the World Health Organization (WHO). Various genetic modifications occurring at the DNA level and the resulting variations in RNA expression give rise to different subcategories that have important implications for diagnosis, prognosis, and treatment. The molecular basis of these morphologic variances is now better understood because of recent developments in molecular biology. With updates on the genetic and clinical characteristics, we highlight the histologic traits of the divergent differentiation and subtypes recognized by the most recent WHO classification (5th edition). Molecular subtypes of lower and upper tract cancer can be used to characterize their clinical behaviors and determine therapeutic responses to neoadjuvant chemotherapy. In this overview article, we also present a preliminary analysis of our ongoing data collection on molecular features of urothelial carcinoma.https://nephropathol.com/PDF/jnp-12-e21482.pdfbladder cancerurothelial carcinomalower tract urothelial carcinomaupper tract urothelial carcinoma
spellingShingle Fateme Khalatbari
Miremad Moafi-Madani
Ali Amin
Urothelial carcinoma; an overview of histology, molecular subtypes, and clinical implications based on the latest WHO classification
Journal of Nephropathology
bladder cancer
urothelial carcinoma
lower tract urothelial carcinoma
upper tract urothelial carcinoma
title Urothelial carcinoma; an overview of histology, molecular subtypes, and clinical implications based on the latest WHO classification
title_full Urothelial carcinoma; an overview of histology, molecular subtypes, and clinical implications based on the latest WHO classification
title_fullStr Urothelial carcinoma; an overview of histology, molecular subtypes, and clinical implications based on the latest WHO classification
title_full_unstemmed Urothelial carcinoma; an overview of histology, molecular subtypes, and clinical implications based on the latest WHO classification
title_short Urothelial carcinoma; an overview of histology, molecular subtypes, and clinical implications based on the latest WHO classification
title_sort urothelial carcinoma an overview of histology molecular subtypes and clinical implications based on the latest who classification
topic bladder cancer
urothelial carcinoma
lower tract urothelial carcinoma
upper tract urothelial carcinoma
url https://nephropathol.com/PDF/jnp-12-e21482.pdf
work_keys_str_mv AT fatemekhalatbari urothelialcarcinomaanoverviewofhistologymolecularsubtypesandclinicalimplicationsbasedonthelatestwhoclassification
AT miremadmoafimadani urothelialcarcinomaanoverviewofhistologymolecularsubtypesandclinicalimplicationsbasedonthelatestwhoclassification
AT aliamin urothelialcarcinomaanoverviewofhistologymolecularsubtypesandclinicalimplicationsbasedonthelatestwhoclassification